Only a final order will affect what products can be marketed. Among the products containing oral phenylephrine as an active ingredient are Sudafed PE, Vicks Nyquil Sinex Nighttime Sinus Relief and ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

Amgen (NASDAQ:AMGN) and AstraZeneca (NASDAQ:AZN) announced Friday that their FDA-approved asthma therapy Tezspire reached ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...

If you are unfortunate enough to come down with sickness, Doctor Sooj said: “Stay well hydrated, as this can soothe your ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps.

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

I recently took a generic 12-hour, maximum-strength nasal decongestant to manage typical sinus pressure and congestion.

I recently took a generic 12-hour, maximum-strength nasal decongestant to manage typical sinus pressure and congestion.

After that, three large, carefully designed studies were conducted—two by Merck for the treatment of seasonal allergies and ...